Cite
MLA Citation
George Fromm et al.. “Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.” Journal for immunotherapy of cancer, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100144253069.0x00002f
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
George Fromm et al.. “Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.” Journal for immunotherapy of cancer, vol. 6, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100144253069.0x00002f